Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
COREGO: drug–drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trials
F Rethouze, Severine Risbourg, Camille Schiffler, Sylvie Chabaud, Antoine De Courreges, Marie‐Cécile Le Deley, Jean Yves Blay, Frédéric Feutry, Marta Jimenez, Marie Vanseymortier, Nicolas Penel, Florence Duffaud, Loïc Lebellec (2025). COREGO: drug–drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trials. , 10(6), DOI: https://doi.org/10.1016/j.esmoop.2025.105117.
Article19 days agoTable S2 from Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A. Cassier, Mitesh J. Borad, Sunil Sharma, Bertrand Dubois, Christophe Caux, Fumiyoshi Okano, Daniel D. Von Hoff, Jean Yves Blay (2025). Table S2 from Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors. , DOI: https://doi.org/10.1158/2767-9764.29539907.
Preprint19 days agoHow should Primary Pulmonary Sarcoma be staged? Results of an International Multicenter Database
Theresa Störk, Dagmar Adámková, Clemens Aigner, Ivan Bravio, Antonella Brunello, Luigi Cerbone, Hugo Clermidy, Lieve De Cock, Silvia Gasperoni, Nicolas Girard, A. Mariuk-Jarema, Rolf Lefering, Enrico Melis, Gloria Marquina, F Mazzeo, Iurii Mykoliuk, Nicolas Penel, Hans‐Ulrich Schildhaus, Sabino Strippoli, Bruno Vincenzi, Sarah Watson, Jean Yves Blay, Sebastian Bauer, Stéphane Collaud (2025). How should Primary Pulmonary Sarcoma be staged? Results of an International Multicenter Database. , 150, DOI: https://doi.org/10.1055/s-0045-1809720.
Article19 days agoTable 1 from Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A. Cassier, Mitesh J. Borad, Sunil Sharma, Bertrand Dubois, Christophe Caux, Fumiyoshi Okano, Daniel D. Von Hoff, Jean Yves Blay (2025). Table 1 from Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors. , DOI: https://doi.org/10.1158/2767-9764.29539922.
Preprint19 days agoTable 3 from Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
Philippe A. Cassier, Mitesh J. Borad, Sunil Sharma, Bertrand Dubois, Christophe Caux, Fumiyoshi Okano, Daniel D. Von Hoff, Jean Yves Blay (2025). Table 3 from Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors. , DOI: https://doi.org/10.1158/2767-9764.29539916.
Preprint19 days ago